Headache |
Cluster Headache; Headaches; Tension Headache |
Clinical Trial: Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache
This study is currently recruiting patients.
Verified by Sorlandet Hospital HF August 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| headache, migraine, analgesics, tension type headache | Drug: prednisone | Phase III |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: Medication Overuse Headache : A Randomised Double Blind Study of Prednisolone or Placebo in Withdrawal Therapy (Phase 3), and a Randomised 1 Year Follow Up by Neurologist or General Physician After Successful Withdrawal Therapy.
Study start: September 2003; Expected completion: September 2008
Last follow-up: January 2007; Data entry closure: January 2007
Eligibility
Inclusion Criteria: Chronic daily headache and medication overuse fulfilling IHS-II criteria -
Exclusion Criteria:Pregnancy, age under 18 and over 70 years, major mental disorders
-
Location and Contact Information
Norway, Vest-Agder
Sørlandet Sykehus HF, Kristiansand, Vest-Agder, 4604, Norway; Recruiting
Magne Geir Bøe, MD, Principal Investigator
Rolf Salvesen, Professor, Study Chair, University of Tromsø
More Information
Last Updated: August 24, 2005
Record first received: August 24, 2005
ClinicalTrials.gov Identifier: NCT00135122
Health Authority: Norway: Directorate for Health and Social Affairs
ClinicalTrials.gov processed this record on 2005-08-30
Resources
- American Council for Headache Education
- Arteriovenous Malformation (National Institute of Neurological Disorders and Stroke)

Not Signed In -

